In this webinar, Ivan Griffin of BenevolentAI will join Laksh Aithani of Charm Therapeutics and Peter Kulka of Goldman Sachs to discuss the opportunities and challenges associated with AI and will answer some pressing questions:
Ivan is COO and a Co-Founder of BenevolentAI. He has 10 years’ experience as a venture capitalist encompassing all aspects of technology commercialization; identification of opportunities, company formation, business development, private and public equity financings and trade sales. He also helped launch Genomics England Ltd, a Company created to deliver the 100,000 Genomes Project as launched by the Prime Minister in 2013. Ivan holds a D.Phil. in Cognitive Neuroscience from the University of Oxford where he also completed a year’s post-doctoral research.
